Form 8-K Anteris Technologies For: Sep 19
Anteris Technologies Global Corp. (AVR)
Company Research
Source: SEC EDGAR
Impact Snapshot
Event Time:
AVR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AVR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AVR alerts
High impacting Anteris Technologies Global Corp. news events
Weekly update
A roundup of the hottest topics
AVR
News
- Anteris Technologies Global (NASDAQ:AVR) had its "sell (e+)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
- Anteris Technologies Presents Data from 100 DurAVR® THV Patients at PCR London ValvesGlobeNewswire
- Anteris Announces Results for the Third Quarter of 2025GlobeNewswire
- FDA Approves Anteris’s DurAVR® THV Global Pivotal Trial (the “PARADIGM Trial”)GlobeNewswire
- Anteris Technologies Global (NASDAQ:AVR) had its "sell (d-)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
AVR
Sec Filings
- 12/4/25 - Form 8-K
- 12/1/25 - Form 8-K
- 11/26/25 - Form S-1
- AVR's page on the SEC website